1. Home
  2. PTCT vs KTB Comparison

PTCT vs KTB Comparison

Compare PTCT & KTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • KTB
  • Stock Information
  • Founded
  • PTCT 1998
  • KTB 2018
  • Country
  • PTCT United States
  • KTB United States
  • Employees
  • PTCT N/A
  • KTB N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • KTB Apparel
  • Sector
  • PTCT Health Care
  • KTB Consumer Discretionary
  • Exchange
  • PTCT Nasdaq
  • KTB Nasdaq
  • Market Cap
  • PTCT 3.9B
  • KTB 3.6B
  • IPO Year
  • PTCT 2013
  • KTB N/A
  • Fundamental
  • Price
  • PTCT $52.13
  • KTB $54.85
  • Analyst Decision
  • PTCT Buy
  • KTB Strong Buy
  • Analyst Count
  • PTCT 14
  • KTB 6
  • Target Price
  • PTCT $67.64
  • KTB $87.50
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • KTB 717.8K
  • Earning Date
  • PTCT 08-07-2025
  • KTB 08-07-2025
  • Dividend Yield
  • PTCT N/A
  • KTB 3.79%
  • EPS Growth
  • PTCT N/A
  • KTB 3.07
  • EPS
  • PTCT 7.51
  • KTB 4.07
  • Revenue
  • PTCT $1,772,758,000.00
  • KTB $2,599,277,000.00
  • Revenue This Year
  • PTCT $120.38
  • KTB $18.35
  • Revenue Next Year
  • PTCT N/A
  • KTB $11.24
  • P/E Ratio
  • PTCT $6.94
  • KTB $13.48
  • Revenue Growth
  • PTCT 91.12
  • KTB 1.08
  • 52 Week Low
  • PTCT $29.02
  • KTB $50.00
  • 52 Week High
  • PTCT $58.38
  • KTB $96.80
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 62.66
  • KTB 23.69
  • Support Level
  • PTCT $44.15
  • KTB $62.83
  • Resistance Level
  • PTCT $52.70
  • KTB $65.38
  • Average True Range (ATR)
  • PTCT 1.87
  • KTB 2.08
  • MACD
  • PTCT 0.59
  • KTB -1.08
  • Stochastic Oscillator
  • PTCT 93.33
  • KTB 9.19

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About KTB Kontoor Brands Inc.

Kontoor Brands Inc is a lifestyle apparel company. It is engaged in designing, manufacturing, sourcing, marketing, and distribution of its portfolio of brands, including Wrangler and Lee. It manufactures its products in owned and leased facilities and distributes the products through both brick-and-mortar and e-commerce retailers. The Company has two reportable segments: Wrangler and Lee. It generates the majority of its revenue from the Wrangler segment. The company's geographical segments are the United States and International, of which the majority of its revenue comes from the United States.

Share on Social Networks: